Chen, Q., Cai, R., Wang, Y., Liang, G., Zhang, K., Yang, X., . . . Tang, J. Profiling triple-negative breast cancer-specific super-enhancers identifies high-risk mesenchymal development subtype and BETi-Targetable vulnerabilities. BMC.
Chicago Style (17th ed.) CitationChen, Qing-shan, et al. Profiling Triple-negative Breast Cancer-specific Super-enhancers Identifies High-risk Mesenchymal Development Subtype and BETi-Targetable Vulnerabilities. BMC.
MLA (9th ed.) CitationChen, Qing-shan, et al. Profiling Triple-negative Breast Cancer-specific Super-enhancers Identifies High-risk Mesenchymal Development Subtype and BETi-Targetable Vulnerabilities. BMC.
Warning: These citations may not always be 100% accurate.